Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details)

v3.25.2
Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 18,833,095 10,272,562 18,833,095 26,368,379
Options to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 1,420,714 1,308,843 1,420,714 1,308,843
Warrants to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 478,419 478,419 478,419 478,419
Restricted Stock Units [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 1,000 1,000
Common stock issuable upon conversion of Series B-1 convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 5,000,000 5,000,000
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 1,115,145 3,484,300 1,115,145 3,484,300
Warrants to purchase convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 15,818,817 15,818,817 16,095,817